COVID-19 RESOURCES FOR HEALTHCARE PROVIDERS
Resources to help you determine the best treatment options for your patients with COVID-19.
FDA PROVIDER FACT SHEETS
Learn more about the products the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to help Combat COVID-19.
- Casirivimab and imdevimab
- Baricitinib (Olumiant) in Combination with remdesivir (Veklury)
- Veklury (remdesivir) Emergency Use Authorization
- Convalescent Plasma Emergency Use Authorization
- REGIOCIT replacement solution that contains citrate for regional citrate anticoagulation (RCA) of the extracorporeal circuit Emergency Use Authorization
- Fresenius Propoven 2% Emulsion Emergency Use Authorization
- multiFiltrate PRO System and multiBic/multiPlus Solutions Emergency Use Authorization
PEER REVIEWED ARTICLES
Explore the following peer-reviewed articles that discuss a range of COVID-19 treatment topics.